Compare Summit Therapeutics Inc (SMMT) vs SpaceX (SPCX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Summit Therapeutics Inc vs SpaceX — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while SpaceX trades at $123.46 (market cap $1.58T). The key difference: SpaceX is far larger — about 150.8× Summit Therapeutics Inc's market cap. Which is the better fit depends on your goals.
| SMMT | SPCX | |
|---|---|---|
Market Cap | $10.48B | $1.58T |
Sector | Health | Technology |
52-Week High | $29.32 | $202.09 |
52-Week Low | $13.05 | $119.85 |
Enterprise Value | $9.90B | $1.59T |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SPCX trades at $123.46, down 0.43% amid bearish technical signals despite recent rebound attempts. The company shows strong revenue growth with $18.67B in 2025 but faces significant profitability challenges with a -45% net income margin. Analyst consensus remains strongly bullish with a $237.78 price target, though upcoming August earnings and share unlock events create near-term uncertainty.
While SpaceX maintains strong revenue momentum and AI infrastructure potential, investors face substantial risks from persistent losses, high valuations, and imminent share dilution. The stock's technical weakness contrasts with Wall Street's long-term optimism, creating a high-risk, high-reward scenario dependent on upcoming earnings execution and competitive positioning.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →About SpaceX
SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.
Read more on SPCX →
